High out-of-pocket costs for medications like Zepbound or Wegovy can also pose significant financial burdens, making it essential to advocate for your coverage
In terms of reduction in BMI, 11 studies (with 349 and 310 subjects from the experimental and control groups, respectively) were included in the analysis
Novo Nordisk oral pipeline Novo Nordisk, the manufacturer of Ozempic and Wegovy, continues developing oral semaglutide formulations
conducted a study involving 283 patients receiving GLP-1 RAs treatment, of whom 35 reported experiencing hair loss (androgenetic alopecia, telogen effluvium, unspecified hair loss)
For a week-by-week side effect log from an athlete's perspective, see the side effects and training breakdown